DESTRIER CAPITAL MANAGEMENT LLC - REPROS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
DESTRIER CAPITAL MANAGEMENT LLC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$2,445,000
+3.9%
329,0300.0%0.72%
+27.3%
Q2 2015$2,353,000
-16.7%
329,0300.0%0.56%
-22.3%
Q1 2015$2,826,000
-13.8%
329,0300.0%0.73%
-17.8%
Q4 2014$3,280,000
-68.6%
329,030
-68.8%
0.88%
-66.2%
Q3 2014$10,431,000
-4.8%
1,053,600
+66.4%
2.62%
-27.9%
Q2 2014$10,957,000
+49.6%
633,350
+53.5%
3.63%
+0.4%
Q1 2014$7,322,000
+89.0%
412,726
+94.9%
3.62%
+40.6%
Q4 2013$3,875,000211,7292.57%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders